MARC details
| 000 -LEADER |
|---|
| fixed length control field |
03784ntm a2200373 i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
vtls000102948 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
KUKTEM |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20251117113356.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
180212s2017 my a f am 000 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
THE0000834(Local) |
| 039 #9 - LEVEL OF BIBLIOGRAPHIC CONTROL AND CODING DETAIL [OBSOLETE] |
|---|
| Level of rules in bibliographic description |
201905271216 |
| Level of effort used to assign nonsubject heading access points |
nazirah |
| -- |
201802121020 |
| -- |
saini |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
UMP |
| Language of cataloging |
eng |
| Transcribing agency |
UMP |
| Description conventions |
rda |
| 090 ## - LOCALLY ASSIGNED LC-TYPE CALL NUMBER (OCLC); LOCAL CALL NUMBER (RLIN) |
|---|
| Classification number (OCLC) (R) ; Classification number, CALL (RLIN) (NR) |
FKKSA .A43 2017 r Bc. |
| 100 0# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Nur Amanina Mohamad Adaris, |
| Relator term |
author. |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Screening of carbamazepine-saccharin (CBC-SAC) co-crystal / |
| Statement of responsibility, etc. |
Nur Amanina Mohamad Adaris |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
Kuantan, Pahang : |
| Name of producer, publisher, distributor, manufacturer |
UMP, |
| Date of production, publication, distribution, manufacture, or copyright notice |
2017 |
| 264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Date of production, publication, distribution, manufacture, or copyright notice |
© 2017 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xv, 61 pages : |
| Other physical details |
illustrations (some color) ; |
| Dimensions |
30 cm. + |
| Accompanying material |
1 CD-ROM |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Source |
rdacontent |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
unmediated |
| Source |
rdamedia |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
computer |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
volume |
| Source |
rdacarrier |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
computer disc |
| Source |
rdacarrier |
| 347 ## - DIGITAL FILE CHARACTERISTICS |
|---|
| File type |
text file |
| Encoding format |
PDF |
| Source |
rda |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Faculty of Chemical & Natural Resources Engineering |
| 502 ## - DISSERTATION NOTE |
|---|
| Dissertation note |
Project Paper (Bachelor of Chemical Engineering) -- Universiti Malaysia Pahang – 2017 |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes bibliographical references and index |
| 520 3# - SUMMARY, ETC. |
|---|
| Summary, etc. |
Co-crystallization is a method in formulation of drug products which is believed to improve drugs solubility, stability and dissolution rate while maintaining the biological functions of its chemical properties. The recent advances in this area have brought this research possible in order to produce pharmaceutical material by crystallization design of carbamazepine (CBZ) using saccharin (SAC) as its co-crystal. This research is conducted to examine formation of carbamazepine-saccharin (CBZ-SAC) co-crystal screening approaches that uses different solvent based crystallization technique in varies solvent system (ethyl acetate solvent and formic acid solvent). In this method, to prepare the co-crystal product CBZ-SAC four crystallization technique are used which are cooling crystallization, solvent crystallization, slurry and stirring in varies solvent of ethyl acetate and formic acid. Different mol ratio of CBZ and SAC are being tested, in order to study CBZ-SAC co-crystal formation. Physical characterization of the co-crystal is being characterized by x-ray powder diffraction (XPRD), differential scanning calorimetry (DSC), fourier transform infrared spectroscopic (FTIR) and optical microscopic. The XPRD analysis had confirmed that only CBZ-SAC co-crystal in ethyl acetate solvent were successfully formed while in formic acid solvent the crystal formed were only SAC. The XRPD pattern profile analysis shown that CBZ-SAC Form I and Form II was produced from different ratios and different methods and it have their own melting point based from the DSC analysis which are 170-172°C and173-177°C respectively. The morphology of the crystal are mostly plate like and needle like shape which indicate Form I and Form II respectively for the polymorphic characterisation. Since two type of polymorph were successfully produced, it is shown that solvent, methods and ratios plays an important role to CBZ-SAC co-crystal formation. Further study in screening is needed for co-crystal formation assessment since there were already many factors proven in affecting the polymorphic formation of the co-crystal such as different methods, solvent and mole ratio. Besides that varies solvent type should be implemented to investigate if the solvent yield CBZ-SAC co-crystal formation and its polymorph. |
| 610 20 - SUBJECT ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
Faculty of Chemical & Natural Resources Engineering |
| General subdivision |
Dissertations |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Universities and Colleges |
| General subdivision |
Dissertations |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Theses |